Daiichi Sankyo Says Has Begun Phase III Tests On Flu Drug

TOKYO, Nov 5 (Reuters) - Daiichi Sankyo (4568. T), Japan's third-largest drugmaker, said on Thursday it has begun Phase III, or last-stage, trials for influenza drug CS-8958. (Reporting by Yumiko Nishitani)...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Swiss voters back minarets ban - Guardian.co.uk

Report: Swiss Vote to Ban New Minarets - FOX WFLD Chicago

Church of Scientology plans Illinois headquarters on Printer's Row: Opening of restored - Individual.com

Saudi floods death toll hits 83 as Hajj continues - Al Arabiya

Abu Dhabi to aid Dubai on case by case basis - TheStar.com.my

Featured Members

Niladri Roy
Manager-International Marketing
Computer Services

Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map